S&P 500 7,481.34 +0.51% NASDAQ 25,734.49 +0.89% DOW 52,016.06 +0.34% R2K 2,954.55 +0.41% VIX 17.98 -3.59% US 10Y 4.64 +0.83% DXY 101.08 +0.09% GOLD 4,054.60 +1.10% CRUDE 84.59 +1.63% BITCOIN 66,698.46 +2.25%
Next Bullish Trade
Sign in
KVUE

Kenvue Inc. NYQ · KVUE

$18.87 -0.15 (-0.79%)
Neutral · -0.08σ
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · KVUE

Momentum reads · latest daily bar
Last
$18.87
-0.15 (-0.79%)
Mkt cap
$36.2B
Consumer Defensive
RSI(14)
51.4
neutral
Stochastic %K
24.3
neutral
MFI(14)
41.4
neutral
ADX(14)
23.6
building

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $3.9B $0.5B $0.8B $0.3B 12.1% 21.4%
2025-12-31 $3.8B $0.3B $0.6B $0.7B 8.7% 16.7%
2025-09-30 $3.8B $0.4B $0.7B $0.2B 10.6% 18.9%
2025-06-30 $3.8B $0.4B $0.8B $0.5B 10.9% 19.6%
2025-03-31 $3.7B $0.3B $0.6B $0.2B 8.6% 16.5%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare KVUE vs peers

Line KVUE up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing KVUE no peers yet — add up to 4 below
Sector peers + WMT + PG + KO + PEP + COST + PM
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with KVUE

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 12 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-05-07 0.32 0.26 +23.0% -0.7%
2026-02-17 0.27 0.22 +21.2% +2.5%
2025-11-03 0.28 0.26 +5.7% -1.1%
2025-08-07 0.29 0.28 +2.2% -1.9%
2025-05-08 0.24 0.23 +5.4% +1.6%
2025-02-06 0.26 0.26 +1.5% +1.9%
2024-11-07 0.28 0.27 +3.0% +3.1%
2024-08-06 0.32 0.28 +15.7% -1.1%
2024-05-07 0.28 0.25 +10.3% +1.8%
2024-02-08 0.31 0.28 +9.8% +0.0%
2023-10-26 0.31 0.31 -1.4% -2.6%
2023-07-20 0.32 0.30 +6.9% -2.0%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Consumer Defensive

Context check: the same key numbers for the closest Consumer Defensive names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
KVUE ★ $36B 22.5 15.2 2.4 12.8 3.4 58.6% 4.5% 46.9% 5.13%
WMT $888B 39.3 34.0 1.2 21.5 9.4 25.0% 7.3% 19.4% 0.77%
PG $344B 21.6 20.9 — 14.9 6.4 51.0% 7.4% 5.8% 3.70%
KO $352B 25.8 23.5 — 23.1 10.5 61.7% 12.1% 18.2% 0.89%
PEP $184B 17.7 15.0 1.9 12.1 8.6 54.2% 6.4% 137.0% 4.25%
COST $411B 46.7 40.9 1.4 30.0 24.9 12.9% 21.5% 45.5% 1.69%
PM — 27.0 21.0 — 18.8 — 67.3% 9.1% -9.3% —
MO $123B 15.4 12.5 — 9.2 -38.4 87.4% 5.3% 106.3% 6.94%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 44.33%

HolderShares% out
Blackrock Inc. 145,297,292 7.57%
FMR, LLC 135,093,094 7.04%
Vanguard Capital Management LLC 124,424,037 6.48%
State Street Corporation 119,571,246 6.23%
Vanguard Portfolio Management LLC 92,464,388 4.82%
Pentwater Capital Management Lp 52,000,000 2.71%
Geode Capital Management, LLC 51,270,216 2.67%
Massachusetts Financial Services Co. 49,743,984 2.59%
Independent Franchise Partners, LLP 49,208,848 2.56%
Millennium Management Llc 31,801,263 1.66%

Insider activity · 90d

13 buys / 2 sells · ratio 6.5 · Finnhub

  • ALLISON RICHARD E JR BUY 49,798
  • Smith Jeffrey C BUY 27,023
  • Howlett Heather SELL 29,288 @ $18.11
  • Mann Erica L BUY 19,986 @ $17.46
  • Godbole Seemantini BUY 36,627 @ $17.46
  • Hofstetter Sarah BUY 24,102 @ $17.46
  • Sneed Michael E BUY 36,627 @ $17.46
  • PAWLUS KATHLEEN M BUY 25,038 @ $17.46
  • ALLISON RICHARD E JR BUY 47,943 @ $17.46
  • Healey Melanie BUY 36,627 @ $17.46

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$18.0
Mean
$19.75
High
$23.0
Analysts
12
Recommendation distribution · period 2026-07-01
2
4
14
Revision trend (2026-04-01 → 2026-07-01): net -3 → 6 +9 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
4 2026-07-01 OWNERSHIP DOCUMENT view ·
4 2026-07-01 FORM 4 view ·
4 2026-06-12 FORM 4 view ·
4 2026-05-26 OWNERSHIP DOCUMENT view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
4 2026-05-26 FORM 4 view ·
8-K 2026-05-22 8-K view ·
4 2026-05-12 FORM 4 view ·
10-Q 2026-05-07 10-Q view ·
8-K 2026-05-07 8-K view ·
8-K 2026-04-15 CURRENT REPORT view ·
DEF 14A 2026-04-08 DEF 14A view ·
4 2026-04-01 OWNERSHIP DOCUMENT view ·
4 2026-03-31 FORM 4 view ·
4 2026-03-12 FORM 4 view ·
4 2026-03-12 FORM 4 view ·
4 2026-03-12 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-09 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
4 2026-03-04 FORM 4 view ·
10-K 2026-02-20 10-K view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
8-K 2026-02-17 8-K view ·
8-K 2026-02-12 CURRENT REPORT view ·
4 2026-02-10 FORM 4 view ·
8-K 2026-01-29 8-K view ·
8-K 2026-01-16 8-K view ·
4 2026-01-06 FORM 4 view ·
4 2026-01-06 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
4 2025-12-17 FORM 4 view ·
4 2025-12-17 FORM 4 view ·

About KVUE

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was inco…

Options picks · KVUE

ITM + OTM ideas from the latest scan

Loading…

Congress trades · KVUE

STOCK Act disclosures

Loading…

SEC filings & insiders · KVUE

EDGAR · live

Loading…

Holders · KVUE

Institutions & insider activity

Loading…